You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

AlzeCure’s Alzheimer’s candidate shows promise

AlzeCure Pharma – a company that develops a portfolio of small molecule candidate drugs for diseases affecting the central nervous system – has announced an abstract regarding its drug candidate NeuroRestore ACD856.